INS and type 2 diabetes mellitus: Given the Delphi Survey was conducted among HCPs with experience in using CGM to manage people with diabetes in primary care, there was a high level of confidence in the impact of using CGM for people with T2D on insulin (Table 2) and 94.3% of respondents agreed or strongly agreed that using CGM supports better decision making in this participant group and can reduce therapeutic inertia in meeting glycaemic goals (97.14%).